Exelixis News, Exelixis Quote, EXEL Quote

Exelixis (NQ:EXEL) Delayed: 51.91 -0.53 (1.01%)

Prev. Close

$52.44

Today 6M 1Y 5Y

Open

$53.07

52 Wk High

$17.00

52 Wk Low

$3.55

Day High

$53.12

Day Low

$50.96

P/E

N/A

EPS

$-1.33

Volume

6,545,172

Friends, Peers and Foes (?): GILD, LEGN, ONC, NTRA, ACAD (more...)

ALERTS | RSS

Jun 3, 2026 06:52 PM Form 4 EXELIXIS, INC. For: Jun 01 Filed by: WYSZOMIERSKI JACK L
Jun 3, 2026 06:52 PM Form 4 EXELIXIS, INC. For: Jun 01 Filed by: Eckhardt Sue Gail
Jun 1, 2026 04:16 PM Form 144 EXELIXIS, INC. Filed by: Eckhardt Sue Gail
Jun 1, 2026 04:06 PM Form 144 EXELIXIS, INC. Filed by: WYSZOMIERSKI JACK L
May 30, 2026 10:00 AM Exelixis reports Cabometyx trial results for neuroendocrine tumors
May 30, 2026 10:00 AM Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
May 29, 2026 05:44 PM Form 4 EXELIXIS, INC. For: May 27 Filed by: PAPADOPOULOS STELIOS
May 29, 2026 05:44 PM Form 4 EXELIXIS, INC. For: May 27 Filed by: Heyman Tomas J.
May 29, 2026 05:44 PM Form 4 EXELIXIS, INC. For: May 27 Filed by: Eckhardt Sue Gail
May 29, 2026 05:43 PM Form 4 EXELIXIS, INC. For: May 27 Filed by: Smith Julie

Entities mentioned with EXEL

View All Entities